高龄父亲影响流产和活产的结果后,第一次转移卵母细胞捐赠周期

IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY
M C Guglielmo, J J Fraire-Zamora, E Bartoli, M Valerio, E De Ponti, A Rodriguez, M Popovic, J Buratini, M R Mignini Renzini, M Dal Canto
{"title":"高龄父亲影响流产和活产的结果后,第一次转移卵母细胞捐赠周期","authors":"M C Guglielmo, J J Fraire-Zamora, E Bartoli, M Valerio, E De Ponti, A Rodriguez, M Popovic, J Buratini, M R Mignini Renzini, M Dal Canto","doi":"10.1093/humrep/deaf097.015","DOIUrl":null,"url":null,"abstract":"Study question Does advanced paternal age affect miscarriage and/or live birth outcomes following the first transfer in oocyte donation cycles? Summary answer Advanced paternal age (>45 years old) increases miscarriage rates and decreases live birth rates following the first transfer in oocyte donation cycles. What is known already Donor oocyte cycles are becoming a common strategy for addressing female age-related infertility, offering high success rates (∼60% ongoing pregnancies) attributed to superior oocyte quality. However, male age-related effects on the success of ART have received less attention. In autologous cycles, advanced paternal age has been associated with poor clinical outcomes. However, disentangling its effects from female factors remains challenging. Oocyte donation cycles offer a useful model for studying the impact of male factors on ART outcomes, eliminating biases related to female age and underlying diagnoses. Study design, size, duration Multi-center, retrospective study of 1,712 first oocyte donation cycles performed between January 2019 and December 2023, across six IVF centers. Only ICSI cycles with fresh donor oocytes, inseminated with frozen partner sperm were included. Only the first single blastocyst transfers (fresh or frozen) were considered. Cycles with abnormal male karyotypes, sperm obtained from testicular biopsy, donor sperm, frozen oocytes, in-vitro matured oocytes or preimplantation genetic testing (PGT) were excluded. Participants/materials, setting, methods Paternal ages were categorized in two groups: ≤45 years old and >45 years old (advanced paternal age, APA). We assessed fertilization rates, the number of usable blastocysts and blastocyst utilization rate. Clinical outcomes included clinical pregnancy, miscarriage and live birth rates. P < 0.05 was considered statistically significant after Fisher’s exact test and a multivariate logistic analysis adjusting for recipient and oocyte age, number of mature (MII) oocytes injected and fresh/frozen embryo transfer. Main results and the role of chance Within the cohort of 1,712 patients who underwent a first oocyte donation cycle, the mean recipient age (±SD) was 43.3 (±4.1) years, the mean oocyte donor age (±SD) was 26.1 (±4.1) years, and the mean paternal age (±SD) was 43.5 (±6.3). In the ≤45 paternal age group (n = 1066), the mean paternal age (±SD) was 39.8 (±4,0) years, while in the APA group (n = 646), it was 49.6 (±4.1). No differences were observed in recipient age, oocyte donor age, number of oocytes fertilized or number of blastocysts obtained among paternal age groups. Interestingly, miscarriage rate was 23.8% (71/298) in the APA group and 16.3% (85/522) in the ≤45 years old group. The differences were significantly different (p = 0.006). Consequently, the live birth rate was also reduced 35.1% APA vs 41.0%, ≤45 years old (227/646 vs 437/1066; p = 0,009). These results were further confirmed in the adjusted analysis, where APA remained significantly associated with a higher miscarriage rate (OR = 1.61, [95%CI: 1.10-2.35], p = 0.014) and a lower live birth rate (OR = 0.77, [95%CI: 0.62–0.96], p = 0.022). Limitations, reasons for caution This study is limited by its retrospective nature. No data on the chromosomal status of the embryos was available. Caution is warranted when generalizing results to different embryo transfer strategies or other patient populations. Wider implications of the findings Our results indicate that paternal age can affect clinical outcomes in oocyte donation cycles. If confirmed in a larger cohort of patients, these results would suggest considering patient counseling in relation to APA when delaying childbearing. Trial registration number No","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":"48 1","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"O-015 Advanced paternal age affects miscarriage and live birth outcomes following the first transfer in oocyte donation cycles\",\"authors\":\"M C Guglielmo, J J Fraire-Zamora, E Bartoli, M Valerio, E De Ponti, A Rodriguez, M Popovic, J Buratini, M R Mignini Renzini, M Dal Canto\",\"doi\":\"10.1093/humrep/deaf097.015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Study question Does advanced paternal age affect miscarriage and/or live birth outcomes following the first transfer in oocyte donation cycles? Summary answer Advanced paternal age (>45 years old) increases miscarriage rates and decreases live birth rates following the first transfer in oocyte donation cycles. What is known already Donor oocyte cycles are becoming a common strategy for addressing female age-related infertility, offering high success rates (∼60% ongoing pregnancies) attributed to superior oocyte quality. However, male age-related effects on the success of ART have received less attention. In autologous cycles, advanced paternal age has been associated with poor clinical outcomes. However, disentangling its effects from female factors remains challenging. Oocyte donation cycles offer a useful model for studying the impact of male factors on ART outcomes, eliminating biases related to female age and underlying diagnoses. Study design, size, duration Multi-center, retrospective study of 1,712 first oocyte donation cycles performed between January 2019 and December 2023, across six IVF centers. Only ICSI cycles with fresh donor oocytes, inseminated with frozen partner sperm were included. Only the first single blastocyst transfers (fresh or frozen) were considered. Cycles with abnormal male karyotypes, sperm obtained from testicular biopsy, donor sperm, frozen oocytes, in-vitro matured oocytes or preimplantation genetic testing (PGT) were excluded. Participants/materials, setting, methods Paternal ages were categorized in two groups: ≤45 years old and >45 years old (advanced paternal age, APA). We assessed fertilization rates, the number of usable blastocysts and blastocyst utilization rate. Clinical outcomes included clinical pregnancy, miscarriage and live birth rates. P < 0.05 was considered statistically significant after Fisher’s exact test and a multivariate logistic analysis adjusting for recipient and oocyte age, number of mature (MII) oocytes injected and fresh/frozen embryo transfer. Main results and the role of chance Within the cohort of 1,712 patients who underwent a first oocyte donation cycle, the mean recipient age (±SD) was 43.3 (±4.1) years, the mean oocyte donor age (±SD) was 26.1 (±4.1) years, and the mean paternal age (±SD) was 43.5 (±6.3). In the ≤45 paternal age group (n = 1066), the mean paternal age (±SD) was 39.8 (±4,0) years, while in the APA group (n = 646), it was 49.6 (±4.1). No differences were observed in recipient age, oocyte donor age, number of oocytes fertilized or number of blastocysts obtained among paternal age groups. Interestingly, miscarriage rate was 23.8% (71/298) in the APA group and 16.3% (85/522) in the ≤45 years old group. The differences were significantly different (p = 0.006). Consequently, the live birth rate was also reduced 35.1% APA vs 41.0%, ≤45 years old (227/646 vs 437/1066; p = 0,009). These results were further confirmed in the adjusted analysis, where APA remained significantly associated with a higher miscarriage rate (OR = 1.61, [95%CI: 1.10-2.35], p = 0.014) and a lower live birth rate (OR = 0.77, [95%CI: 0.62–0.96], p = 0.022). Limitations, reasons for caution This study is limited by its retrospective nature. No data on the chromosomal status of the embryos was available. Caution is warranted when generalizing results to different embryo transfer strategies or other patient populations. Wider implications of the findings Our results indicate that paternal age can affect clinical outcomes in oocyte donation cycles. If confirmed in a larger cohort of patients, these results would suggest considering patient counseling in relation to APA when delaying childbearing. Trial registration number No\",\"PeriodicalId\":13003,\"journal\":{\"name\":\"Human reproduction\",\"volume\":\"48 1\",\"pages\":\"\"},\"PeriodicalIF\":6.0000,\"publicationDate\":\"2025-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Human reproduction\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/humrep/deaf097.015\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human reproduction","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/humrep/deaf097.015","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

研究问题:父亲的高龄是否会影响卵子捐赠周期中第一次移植后的流产和/或活产结局?高龄父亲(45岁)增加流产率,降低卵子捐赠周期中第一次移植后的活产率。已知的供体卵母细胞周期正在成为解决女性年龄相关性不孕症的常用策略,由于卵母细胞质量优越,提供高成功率(持续妊娠约60%)。然而,男性年龄对抗逆转录病毒治疗成功的影响却很少受到关注。在自体周期中,父亲年龄大与临床预后差有关。然而,将其影响与女性因素分开仍然具有挑战性。卵母细胞捐赠周期为研究男性因素对ART结果的影响提供了一个有用的模型,消除了与女性年龄和潜在诊断相关的偏见。研究设计、规模、持续时间对2019年1月至2023年12月期间在6个试管婴儿中心进行的1712个首次卵母细胞捐赠周期进行多中心回顾性研究。仅包括新鲜供体卵母细胞与冷冻伴侣精子受精的ICSI周期。只考虑第一次单个囊胚移植(新鲜或冷冻)。排除男性核型异常的周期、睾丸活检获得的精子、供体精子、冷冻卵母细胞、体外成熟卵母细胞或植入前遗传学检测(PGT)。参与者/材料、环境、方法父亲年龄分为≤45岁和≥45岁两组(父亲高龄,APA)。我们评估了受精率、可用囊胚数量和囊胚利用率。临床结果包括临床妊娠、流产和活产率。P, lt;经Fisher精确检验和调整受体和卵母细胞年龄、注射成熟卵母细胞数量和新鲜/冷冻胚胎移植的多因素logistic分析后,0.05被认为具有统计学意义。在1712例接受第一次卵母细胞捐赠周期的患者中,平均受体年龄(±SD)为43.3(±4.1)岁,平均卵母细胞供体年龄(±SD)为26.1(±4.1)岁,平均父亲年龄(±SD)为43.5(±6.3)岁。父亲年龄≤45岁组(n = 1066)平均年龄(±SD)为39.8(±4,0)岁,而APA组(n = 646)平均年龄为49.6(±4.1)岁。在受体年龄、卵母细胞供体年龄、受精卵母细胞数和获得囊胚数方面,不同年龄的父系间无差异。有趣的是,APA组流产率为23.8%(71/298),≤45岁组流产率为16.3%(85/522)。差异有统计学意义(p = 0.006)。因此,活产率也下降了35.1%,APA比41.0%,≤45岁(227/646比437/1066;P = 0.009)。这些结果在调整后的分析中得到进一步证实,APA仍然与较高的流产率(OR = 1.61, [95%CI: 1.10-2.35], p = 0.014)和较低的活产率(OR = 0.77, [95%CI: 0.62-0.96], p = 0.022)显著相关。本研究的局限性在于其回顾性研究的性质。没有关于胚胎染色体状况的数据。当将结果推广到不同的胚胎移植策略或其他患者群体时,需要谨慎。我们的研究结果表明,父亲的年龄可以影响卵母细胞捐赠周期的临床结果。如果在更大的患者队列中得到证实,这些结果将建议在推迟生育时考虑与APA相关的患者咨询。试验注册号
本文章由计算机程序翻译,如有差异,请以英文原文为准。
O-015 Advanced paternal age affects miscarriage and live birth outcomes following the first transfer in oocyte donation cycles
Study question Does advanced paternal age affect miscarriage and/or live birth outcomes following the first transfer in oocyte donation cycles? Summary answer Advanced paternal age (>45 years old) increases miscarriage rates and decreases live birth rates following the first transfer in oocyte donation cycles. What is known already Donor oocyte cycles are becoming a common strategy for addressing female age-related infertility, offering high success rates (∼60% ongoing pregnancies) attributed to superior oocyte quality. However, male age-related effects on the success of ART have received less attention. In autologous cycles, advanced paternal age has been associated with poor clinical outcomes. However, disentangling its effects from female factors remains challenging. Oocyte donation cycles offer a useful model for studying the impact of male factors on ART outcomes, eliminating biases related to female age and underlying diagnoses. Study design, size, duration Multi-center, retrospective study of 1,712 first oocyte donation cycles performed between January 2019 and December 2023, across six IVF centers. Only ICSI cycles with fresh donor oocytes, inseminated with frozen partner sperm were included. Only the first single blastocyst transfers (fresh or frozen) were considered. Cycles with abnormal male karyotypes, sperm obtained from testicular biopsy, donor sperm, frozen oocytes, in-vitro matured oocytes or preimplantation genetic testing (PGT) were excluded. Participants/materials, setting, methods Paternal ages were categorized in two groups: ≤45 years old and >45 years old (advanced paternal age, APA). We assessed fertilization rates, the number of usable blastocysts and blastocyst utilization rate. Clinical outcomes included clinical pregnancy, miscarriage and live birth rates. P < 0.05 was considered statistically significant after Fisher’s exact test and a multivariate logistic analysis adjusting for recipient and oocyte age, number of mature (MII) oocytes injected and fresh/frozen embryo transfer. Main results and the role of chance Within the cohort of 1,712 patients who underwent a first oocyte donation cycle, the mean recipient age (±SD) was 43.3 (±4.1) years, the mean oocyte donor age (±SD) was 26.1 (±4.1) years, and the mean paternal age (±SD) was 43.5 (±6.3). In the ≤45 paternal age group (n = 1066), the mean paternal age (±SD) was 39.8 (±4,0) years, while in the APA group (n = 646), it was 49.6 (±4.1). No differences were observed in recipient age, oocyte donor age, number of oocytes fertilized or number of blastocysts obtained among paternal age groups. Interestingly, miscarriage rate was 23.8% (71/298) in the APA group and 16.3% (85/522) in the ≤45 years old group. The differences were significantly different (p = 0.006). Consequently, the live birth rate was also reduced 35.1% APA vs 41.0%, ≤45 years old (227/646 vs 437/1066; p = 0,009). These results were further confirmed in the adjusted analysis, where APA remained significantly associated with a higher miscarriage rate (OR = 1.61, [95%CI: 1.10-2.35], p = 0.014) and a lower live birth rate (OR = 0.77, [95%CI: 0.62–0.96], p = 0.022). Limitations, reasons for caution This study is limited by its retrospective nature. No data on the chromosomal status of the embryos was available. Caution is warranted when generalizing results to different embryo transfer strategies or other patient populations. Wider implications of the findings Our results indicate that paternal age can affect clinical outcomes in oocyte donation cycles. If confirmed in a larger cohort of patients, these results would suggest considering patient counseling in relation to APA when delaying childbearing. Trial registration number No
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Human reproduction
Human reproduction 医学-妇产科学
CiteScore
10.90
自引率
6.60%
发文量
1369
审稿时长
1 months
期刊介绍: Human Reproduction features full-length, peer-reviewed papers reporting original research, concise clinical case reports, as well as opinions and debates on topical issues. Papers published cover the clinical science and medical aspects of reproductive physiology, pathology and endocrinology; including andrology, gonad function, gametogenesis, fertilization, embryo development, implantation, early pregnancy, genetics, genetic diagnosis, oncology, infectious disease, surgery, contraception, infertility treatment, psychology, ethics and social issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信